Budd-Chiari syndrome

Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology. 2003;38:793-803. Abstract

Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004;350:578-585. Abstract

European Association for the Study of the Liver. EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol. 2016;64:179-202.Full text  Abstract

Socie G, Mary JY, de Gramont A, et al. Paroxysmal nocturnal haemoglobinuria: long term follow-up and prognostic factors. Lancet. 1996;348:573-577. Abstract

Perelló A, García-Pagán JC, Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology. 2002;35:132-139.Full text  Abstract

1. DeLeve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764.Full text  Abstract

2. Hoekstra J, Janssen HL. Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome. Neth J Med. 2008;66:334-339.Full text  Abstract

3. Senzolo M, Cholongitas EC, Patch D, et al. Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol. 2005;2:182-190.Full text  Abstract

4. Dilawari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore). 1994;73:21-36. Abstract

5. Mitchell MC, Boitnott JK, Kaufman S, et al. Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore). 1982;61:199-218. Abstract

6. Hemming AW, Langer B, Greig P, et al. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg. 1996;171:176-180. Abstract

7. Hadengue A, Poliquin M, Vilgrain V, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology. 1994;106:1042-1047. Abstract

8. Murad SD, Valla DC, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004;39:500-508. Abstract

9. Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis. 2002;22:5-14. Abstract

10. Kage M, Arakawa M, Kojioro M, et al. Histopathology of membranous obstruction of the inferior vena cava in the Budd-Chiari syndrome. Gastroenterology. 1992;102:2081-2090. Abstract

11. Shrestha SM, Okuda K, Uchida T, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol. 1996;11:170-179. Abstract

12. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology. 2003;38:793-803. Abstract

13. Parker RG. Occlusion of the hepatic veins in man. Medicine (Baltimore). 1959;38:369-402. Abstract

14. Armstrong CD, Carnes WH. Obstruction of the hepatic veins (Chiari's disease): report of five cases. Am J Med Sci. 1944;208:470-478.

15. Sequeira FW, Weber TR, Smith WL, et al. Budd-Chiari syndrome caused by hepatic torsion. Am J Roentgenol. 1981;137:393-394.Full text  Abstract

16. Mahmoud AE, Mendoza A, Meshikhes AN, et al. Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM. 1996;89:37-43.Full text  Abstract

17. Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis. 2002;22:15-26. Abstract

18. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood. 2000;96:2364-2368.Full text  Abstract

19. Denninger MH, Chaït Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000;31:587-591. Abstract

20. Valla D, Casadevall N, Lacombe C, et al. Primary myeloproliferative disorder and hepatic vein thrombosis: a prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med. 1985;103:329-334. Abstract

21. Mohanty D, Shetty S, Ghosh K, et al. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from western India. Hepatology. 2001;34:666-670.Full text  Abstract

22. Espinosa G, Font J, Garcia-Pagan JC, et al. Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine (Baltimore). 2001;80:345-354. Abstract

23. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346:752-763. Abstract

24. Minnema MC, Janssen HL, Niermeijer P, et al. Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability. J Hepatol. 2000;33:509-512. Abstract

25. Valla D, Le MG, Poynard T, et al. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives: a case-control study. Gastroenterology. 1986;90:807-811. Abstract

26. Samborek M, Drosdzol A, Stojko R, et al. Budd-Chiari syndrome induced by hormonal oral contraception in the patient with congenital thrombophilia-factor V Leiden mutation - a case report. Ginekol Pol. 2008;79:702-705. Abstract

27. Cazals-Hatem D, Vilgrain V, Genin P, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology. 2003;37:510-519.Full text  Abstract

28. McCuskey RS. Morphological mechanisms for regulating blood flow through hepatic sinusoids. Liver. 2000;20:3-7. Abstract

29. Murad SD, Plessier A, Hernandez-Guerra M, et al. A prospective follow-up study on 163 patients with Budd-Chiari syndrome: results from the European Network for Vascular Disorders of the Liver (EN-VIE). J Hepatol. 2007;46(Suppl 1):S4.Full text

30. Ohta M, Hashizume M, Tomikawa M, et al. Analysis of hepatic vein waveform by Doppler ultrasonography in 100 patients with portal hypertension. Am J Gastroenterol. 1994;89:170-175. Abstract

31. Buckley O, O'Brien J, Snow A, et al. Imaging of Budd-Chiari syndrome. Eur Radiol. 2007;17:2071-2078. Abstract

32. Kamath PS. Budd-Chiari syndrome: radiologic findings. Liver Transpl. 2006;12(suppl 2):S21-S22. Abstract

33. Noone TC, Semelka RC, Siegelman ES, et al. Budd-Chiari syndrome: spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging. J Magn Reson Imaging. 2000;11:44-50. Abstract

34. Erden A. Budd-Chiari syndrome: a review of imaging findings. Eur J Radiol. 2007;61:44-56. Abstract

35. Janssen HL, Garcia-Pagan JC, Elias E, et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38:364-371.Full text  Abstract

36. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005 Mar 19-25;365(9464):1054-61. Abstract

37. Qi X, Yang Z, Bai M, et al. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis. Aliment Pharmacol Ther. 2011;33:1087-1103. Abstract

38. Brière JB. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management. Semin Thromb Hemost. 2006;32:208-218. Abstract

39. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004;350:578-585. Abstract

40. Tang TJ, Batts KP, de Groen PC, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol. 2001;35:338-343. Abstract

41. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:5332-5340.Full text  Abstract

42. Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology. 1998;27:488-496.Full text  Abstract

43. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis. 2002;22:27-42. Abstract

44. Salat C, Holler E, Kolb HJ, et al. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood. 1997;89:2184-2188.Full text  Abstract

45. Yoshimoto K, Ono N, Okamura T, et al. Recent progress in the diagnosis and therapy for veno-occlusive disease of the liver. Leuk Lymphoma. 2003;44:229-234. Abstract

46. Shulman HM, McDonald GB, Matthews D, et al. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology. 1980;79:1178-1191. Abstract

47. Bargalló X, Gilabert R, Nicolau C, et al. Sonography of Budd-Chiari syndrome. Am J Roentgenol. 2006;187:W33-W41.Full text  Abstract

48. Frank JW, Kamath PS, Stanson AW. Budd-Chiari syndrome: early intervention with angioplasty and thrombolytic therapy. Mayo Clin Proc. 1994;69:877-881. Abstract

49. European Association for the Study of the Liver. EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol. 2016;64:179-202.Full text  Abstract

50. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology. 2006;44:1308-1316.Full text  Abstract

51. De Franchis R. Evolving consensus in portal hypertension: report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167-176.Full text  Abstract

52. Sholar PW, Bell WR. Thrombolytic therapy for inferior vena cava thrombosis in paroxysmal nocturnal hemoglobinuria. Ann Intern Med. 1985;103:539-541. Abstract

53. Alioglu B, Avci Z, Aytekin C, et al. Budd-Chiari syndrome in a child due to a membranous web of the inferior vena cava resolved by systemic and local recombinant tissue plasminogen activator treatment. Blood Coagul Fibrinolysis. 2006;17:209-212. Abstract

54. Hillmen P, Muus P, Dührsen U, et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2007;110:4123-4128.Full text  Abstract

55. Rhee J, Demetris AJ, Abu Elmagd K, et al. Suprahepatic Budd-Chiari syndrome treated with thrombectomy and cavoplasty. Dig Dis Sci. 2003;48:1637-1641. Abstract

56. Yang XL, Cheng TO, Chen CR. Successful treatment by percutaneous balloon angioplasty of Budd-Chiari syndrome caused by membranous obstruction of inferior vena cava: 8-year follow-up study. J Am Coll Cardiol. 1996;28:1720-1724. Abstract

57. Cooper S, Olliff S, Elias E. Recanalisation of hepatic veins by a combined transhepatic, transjugular approach in three cases of Budd Chiari syndrome. J Interv Radiol. 1996;11:9-13.

58. Eapen CE, Velissaris D, Heydtmann M, et al. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006 Jun;55(6):878-84.Full text  Abstract

59. Pelage JP, Denys A, Valla D, et al. Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents. Eur Radiol. 2003;13:286-293. Abstract

60. Rogopoulos A, Gavelli A, Sakai H, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome after failure of surgical shunting. Arch Surg. 1995;130:227-228. Abstract

61. Beckett D, Olliff S. Interventional radiology in the management of Budd Chiari syndrome. Cardiovasc Intervent Radiol. 2008;31:839-847. Abstract

62. Lee BB, Villavicencio L, Kim YW, et al. Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. J Vasc Surg. 2006;43:101-108. Abstract

63. Wu T, Wang L, Xiao Q, et al. Percutaneous balloon angioplasty of inferior vena cava in Budd-Chiari syndrome-R1. Int J Cardiol. 2002;83:175-178. Abstract

64. LaBerge JM, Ring EJ, Lake JR, et al. Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients. J Vasc Surg. 1992;16:258-267. Abstract

65. Ochs A, Sellinger M, Haag K, et al. Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol. 1993;18:217-225. Abstract

66. Watanabe H, Shinzawa H, Saito T, et al. Successful emergency treatment with a transjugular intrahepatic portosystemic shunt for life-threatening Budd-Chiari syndrome with portal thrombotic obstruction. Hepatogastroenterology. 2000;47:839-841. Abstract

67. Ganger DR, Klapman JB, McDonald V, et al. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol. 1999;94:603-608. Abstract

68. Hernandez-Guerra M, Turnes J, Rubinstein P, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology. 2004;40:1197-1202.Full text  Abstract

69. Wang ZG, Jones RS. Budd-Chiari syndrome. Curr Probl Surg. 1996;33:83-211. Abstract

70. Senning A. Transcaval posterocranial resection of the liver as treatment of the Budd-Chiari syndrome. World J Surg. 1983;7:632-640. Abstract

71. Ringe B, Lang H, Oldhafer KJ, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology. 1995;21:1337-1344. Abstract

72. Ara C, Akbulut S, Ince V, et al. Living donor liver transplantation for Budd-Chiari syndrome: Overcoming a troublesome situation. Medicine (Baltimore). 2016 Oct;95(43):e5136.Full text  Abstract

73. Yamada T, Tanaka K, Ogura Y, et al. Surgical techniques and long-term outcomes of living donor liver transplantation for Budd-Chiari syndrome. Am J Transplant. 2006;6:2463-2469. Abstract

74. Zhang Q, Xu H, Zu M, et al. Catheter-directed thrombolytic therapy combined with angioplasty for hepatic vein obstruction in Budd-Chiari syndrome complicated by thrombosis. Exp Ther Med. 2013 Oct;6(4):1015-1021.Full text  Abstract

75. Bismuth H, Sherlock DJ. Portasystemic shunting versus liver transplantation for the Budd Chiari syndrome. Ann Surg. 1991;214:581-589.Full text  Abstract

76. Mahmoud AE, Elias E, Beauchamp N, et al. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut. 1997;40:798-800.Full text  Abstract

77. Darwish Murad S, Valla DC, de Groen PC, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol. 2006;101:83-90. Abstract

78. Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal haemoglobinuria. New Engl J Med. 1995;333:1253-1259.Full text  Abstract

79. Socie G, Mary JY, de Gramont A, et al. Paroxysmal nocturnal haemoglobinuria: long term follow-up and prognostic factors. Lancet. 1996;348:573-577. Abstract

80. McCarthy PM, van Heerden JA, Adson MA, et al. The Budd-Chiari syndrome: medical and surgical management of 30 patients. Arch Surg. 1985;120:657-662. Abstract

81. Ahn SS, Yellin A, Sheng FC, et al. Selective surgical therapy of the Budd-Chiari syndrome provides superior survivor rates than conservative medical management. J Vasc Surg. 1987;5:28-37. Abstract

82. Zhang CQ, Fu LN, Xu L, et al. Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gastroenterol. 2003;9:2587-2591.Full text  Abstract

83. Garcia-Pagán JC, Heydtmann M, Raffa S, et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology. 2008;135:808-815. Abstract

84. Perelló A, García-Pagán JC, Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology. 2002;35:132-139.Full text  Abstract

85. Schattenfroh N, Bechstein WO, Blumhardt G, et al. Liver transplantation for PNH with Budd-Chiari syndrome: a case report. Transpl Int. 1993;6:354-358. Abstract

86. Slakey DP, Klein AS, Venbrux AC, et al. Budd-Chiari syndrome: current management options. Ann Surg. 2001;233:522-527.Full text  Abstract

87. Mentha G, Giostra E, Majno PE, et al. Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol. 2006;44:520-528. Abstract

88. Knoop M, Lemmens HP, Langrehr JM, et al. Liver transplantation for Budd-Chiari syndrome. Transplant Proc. 1994;26:3577-3578. Abstract

89. Smalberg JH, Darwish Murad S, Braakman E, et al. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome. Haematologica. 2006;91:1712-1713.Full text  Abstract

90. Elliot MS, Immelman EJ, Jeffery P, et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg. 1979;66:838-843. Abstract

91. Holland-Fischer P, Gronbaek H, Astrup L, et al. Budd-Chiari and inferior caval vein syndromes due to membranous obstruction of liver veins: successful treatment with angioplasty and transcaval transjugular intrahepatic porto-systemic shunt. Scand J Gastroenterol. 2004;39:1025-1028. Abstract

92. Ren W, Qi X, Yang Z, et al. Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review. Eur J Gastroenterol Hepatol. 2013 Jul;25(7):830-41. Abstract

93. Bayraktar Y, Egesel T, Saglam F, et al. Does hepatic vein outflow obstruction contribute to the pathogenesis of hepatocellular carcinoma? J Clin Gastroenterol. 1998;27:67-71. Abstract